Neurorbalin Capsule 75mg (Pregabalin)

Adult dose

This medication should be taken orally, divided into two doses daily, regardless of food intake. 1. Neuropathic Pain - Peripheral neuropathic pain: Starting dose of 150 mg once daily can be given, and can be increased to 300 mg once daily within 3 to 7 days, then further increased to a maximum of 600 mg daily at intervals of 7 days. - Central neuropathic pain: Starting dose of 150 mg once daily, can be increased to 300 mg once daily after one week.

Child dose

The safety and efficacy of this medication in children under 12 years of age and adolescents aged 12 to 17 years are insufficient, and its use is not recommended.

This medication may increase the risk of suicidal thoughts or behavior, so report any mood changes or symptoms of depression to your healthcare provider immediately while taking it. Do not use if allergic to any of the ingredients in this medication, and patients with lactose intolerance should also avoid it. Diabetic patients should be cautious as weight gain after taking this medication may require adjustment of their blood sugar control medication. If symptoms of angioedema occur, stop taking the medication immediately and consult your healthcare provider. Elderly patients should be especially cautious during initial dosing due to the risk of falls from dizziness and drowsiness. This medication can cause visual disturbances such as blurred vision or changes in eyesight, and patients should inform their healthcare provider if symptoms occur. Patients with a history of drug abuse may be at increased risk for misuse of this medication, requiring careful use. Patients with impaired renal function may need dose adjustments; consult with your healthcare provider regarding this. Concomitant use of this medication and opioid analgesics may increase the risk of central nervous system depression, so caution is advised. During early pregnancy, this medication may affect the fetus, and women who are pregnant or planning to become pregnant should consult with their healthcare provider. Patients experiencing dizziness or drowsiness should avoid driving or operating hazardous machinery. Patients experiencing severe skin rash or allergic symptoms should stop taking the medication immediately and inform their healthcare provider. In case of overdose, symptoms such as confusion, drowsiness, depression, or seizures may occur, requiring caution, and treatment such as dialysis may be necessary. Keep out of the reach of children, and avoid transferring to other containers. This medication is not recommended for breastfeeding women; a decision should be made considering breastfeeding status and the benefits of treatment. Elderly patients may require dose adjustments due to delayed drug elimination caused by decreased renal function.

Serious side effects

• Hives
• angioedema
• facial swelling
• periorbital edema
• upper airway edema
• mucocutaneous syndrome
• Stevens-Johnson syndrome
• toxic epidermal necrolysis
• cold sweats
• difficulty breathing

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

Store this medication in a tightly closed container to protect it from air and moisture. It is important to maintain the storage temperature between 15 to 30 degrees Celsius.

Appearance

Hard capsule with reddish brown upper part and white lower part filled with white or light yellow powder

Package unit

30 capsules/bottle, 100 capsules/bottle